StreetAlpha.app
Home › Stocks › IRMD

Iradimed Corp (IRMD)

$81.02
▼ −0.30%
LAST CLOSE · NOV 20

IRADIMED makes MRI compatible IV infusion pumps and patient vital signs monitors for hospitals and acute care facilities. It last closed at $81.02 on Nov 20, down 0.30% on the day. The next earnings report for IRMD is expected around Tue, Feb 9, 2027. For the quarter ended Sep 2026, IRMD reported EPS of $0.51 on revenue of $24.2M, with revenue up 14.2% from a year ago. Over its last 8 reports the stock moved an average of 7.3% the session after earnings. Over the last 12 months IRMD insiders bought $0 of stock on the open market and sold $16.7M, according to SEC Form 4 filings.

AI Auto Pilots
Is IRMD in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold IRMD.

Key Stats

Last 12 months
Results
Revenue
$89.3M
+11.0% vs a year ago
Net income
$24.0M
+13.2% vs a year ago
EPS (diluted)
$1.87
+13.3% vs a year ago
Free cash flow
$26.1M
29.3% margin
Valuation
Market cap
$1.0B
12.8M shares
P/E
43.3
Price over 12 month EPS
Price to sales
11.6
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$63.3M
At Sep 30
Shareholder equity
$106.5M
Shares outstanding
12.8M
At Oct 30
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $41.8M$41.8MFY2021FY2022: $53.3M$53.3MFY2022FY2023: $65.6M$65.6MFY2023FY2024: $73.2M$73.2MFY2024FY2025: $83.8M$83.8MFY2025

From IRMD's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 30). Last 12 months adds up the four latest quarters.

Next report
Feb 9
Estimated date · Time not announced
Reported EPS
$0.51
Quarter ended Sep 2026
Year ago EPS
$0.43
+18.6% on a GAAP basis
Revenue
$24.2M
+14.2% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.40Dec '24Mar 2025: $0.37Mar '25Jun 2025: $0.45Jun '25Sep 2025: $0.43Sep '25Dec 2025: $0.50Dec '25Mar 2026: $0.45Mar '26Jun 2026: $0.41Jun '26Sep 2026: $0.51Sep '26Latest $0.51
Revenue by quarter
Dec 2024: $19.4MDec '24Mar 2025: $19.5MMar '25Jun 2025: $20.4MJun '25Sep 2025: $21.2MSep '25Dec 2025: $22.7MDec '25Mar 2026: $22.0MMar '26Jun 2026: $20.5MJun '26Sep 2026: $24.2MSep '26Latest $24.2M
How IRMD moved after its last 8 reports
Average move the session after a report ±7.3%
Oct 30, 2026Time not announced−10.6%
May 1, 2026Time not announced+4.5%
Feb 10, 2026Time not announced+9.6%
Nov 3, 2025Time not announced+9.5%
Aug 1, 2025Time not announced+13.4%
May 5, 2025Time not announced−2.2%
Feb 13, 2025Time not announced−8.4%
Jan 10, 2025After the close−0.1%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on IRMDStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Technical Analysis

IRMD · as of the Nov 20 close · updated each morning
Downtrend

The stock is 4% below its 20 day and 5% below its 50 day average. It is 13% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 39). The nearest support is the Pivot S1 at $80.39, and the nearest resistance the Pivot at $81.25.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 3.3%/day
Key levels
$107.9052 week high+33.2%
$91.39200 day average+12.8%
$88.16100 day average+8.8%
$86.93Swing high (Oct 29)+7.3%
$85.2450 day average+5.2%
$83.9820 day average+3.7%
$81.88Pivot R1+1.1%
$81.25Pivot+0.3%
$81.02Last close
$80.39Pivot S1−0.8%
$76.3552 week low−5.8%
$76.35Swing low (Oct 30)−5.8%
Indicators
RSI (14)39.40Weak, oversold below 30Neutral
MACD-0.91Below its signal lineBearish
Stochastic31.6Middle of its rangeNeutral
ADX (14)13.8No clear trend
Williams %R-81.7Oversold below −80, overbought above −20Oversold
CCI (20)-90.8Oversold below −100, overbought above 100Neutral
Rate of change−6.1%Change over 10 sessionsBearish
ATR (14)$2.69Typical daily range, 3.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for IRMD

What happened before

See how IRMD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow IRMD usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How IRMD has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2014.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for IRMDHow many large options trades hit IRMD, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

IRMD Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●104 buying vs 96 selling
  • ●Held by funds +0.4 pts
  • ●Funds holding +2
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding215213+0.9%
In funds' top 10220.0%
Held by funds61.8%61.4%+0.4 pts
New / increased28 / 7617 / 97−8.8%
Reduced / sold out71 / 2561 / 29+6.7%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See IRMD institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

IRMD Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$16.7M30 sales · 5 insiders
46% of the selling was under pre-arranged trading plans.
2025-12 sold $4.1M2026-01 sold $2.0M2026-02 sold $100K2026-03 sold $3.7M2026-04 sold $2.8M2026-05 sold $2.6M2026-06 sold $512K2026-09 sold $123KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Sep 3Monty K AllenDirectorSale1,419$86.41$123K
Jun 4Hilda Frederique Scharen-GuivelDirectorSale3,000$95.00$285K
Jun 1Roger E. SusiCEO, President, ChairmanSale plan2,500$90.60$227K
May 27Roger E. SusiCEO, President, ChairmanSale plan7,500$92.14$691K
May 19Roger E. SusiCEO, President, ChairmanSale plan7,500$87.64$657K
May 12Roger E. SusiCEO, President, ChairmanSale plan7,500$84.18$631K
Every insider buy and sale for IRMD over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See IRMD insider trades →

From SEC Form 4 filings by IRMD's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IRMD is in one of them and how their past IRMD trades turned out.

IRMD in the AI portfolios
Loading…

IRMD News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered IRMD in an article yet. Here's the latest on the wider market.

IRMD in the news

About Iradimed

IRADIMED designs, makes and sells medical devices that are safe to use during magnetic resonance imaging (MRI) scans. Its main products are MRI compatible IV infusion pumps, which deliver anesthesia and other fluids to patients during scans, and a vital signs monitoring system that moves with patients between critical care units and the MRI room. The company also sells related accessories, disposable IV tubing sets and maintenance services. Based in Orlando, Florida, it sells mainly to hospitals and acute care facilities in the United States and abroad.

Headquarters
Orlando, FL